JP6648004B2 - 朝鮮人参の実抽出物を含む脳活性化組成物 - Google Patents

朝鮮人参の実抽出物を含む脳活性化組成物 Download PDF

Info

Publication number
JP6648004B2
JP6648004B2 JP2016506227A JP2016506227A JP6648004B2 JP 6648004 B2 JP6648004 B2 JP 6648004B2 JP 2016506227 A JP2016506227 A JP 2016506227A JP 2016506227 A JP2016506227 A JP 2016506227A JP 6648004 B2 JP6648004 B2 JP 6648004B2
Authority
JP
Japan
Prior art keywords
ginseng
berry extract
ginseng berry
composition
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016506227A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016515611A5 (https=
JP2016515611A (ja
Inventor
ヒョン ジョン シン，
ヒョン ジョン シン，
チャン ウン パク，
チャン ウン パク，
ス フヮン キム，
ス フヮン キム，
デ バン ソ，
デ バン ソ，
ウァン ギ キム，
ウァン ギ キム，
サン ジュン イ，
サン ジュン イ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of JP2016515611A publication Critical patent/JP2016515611A/ja
Publication of JP2016515611A5 publication Critical patent/JP2016515611A5/ja
Application granted granted Critical
Publication of JP6648004B2 publication Critical patent/JP6648004B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016506227A 2013-04-02 2014-03-27 朝鮮人参の実抽出物を含む脳活性化組成物 Active JP6648004B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2013-0035600 2013-04-02
KR20130035600 2013-04-02
KR1020140033892A KR102200012B1 (ko) 2013-04-02 2014-03-24 인삼열매 추출물을 포함하는 뇌 활성화 조성물
KR10-2014-0033892 2014-03-24
PCT/KR2014/002612 WO2014163328A1 (ko) 2013-04-02 2014-03-27 인삼열매 추출물을 포함하는 뇌 활성화 조성물

Publications (3)

Publication Number Publication Date
JP2016515611A JP2016515611A (ja) 2016-05-30
JP2016515611A5 JP2016515611A5 (https=) 2019-11-21
JP6648004B2 true JP6648004B2 (ja) 2020-02-14

Family

ID=51992238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016506227A Active JP6648004B2 (ja) 2013-04-02 2014-03-27 朝鮮人参の実抽出物を含む脳活性化組成物

Country Status (6)

Country Link
US (1) US10555983B2 (https=)
EP (1) EP2982376B1 (https=)
JP (1) JP6648004B2 (https=)
KR (1) KR102200012B1 (https=)
CN (2) CN104095894A (https=)
WO (1) WO2014163328A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6655005B2 (ja) * 2013-04-02 2020-02-26 アモーレパシフィック コーポレーションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ 薬用人参の実エキスを含有する女性の健康及び生活の質改善用組成物
KR102348044B1 (ko) 2015-02-13 2022-01-10 (주)아모레퍼시픽 번아웃증후군의 예방, 개선 또는 치료용 조성물
KR102065503B1 (ko) * 2018-04-23 2020-01-13 주식회사 한국인삼공사 인삼 추출물의 분획물을 포함하는 학습장애, 인지장애 또는 기억력 손상 예방 또는 치료용 조성물
JP2019218284A (ja) * 2018-06-18 2019-12-26 オンガネジャパン株式会社 若齢者学習能力向上のための経口組成物及び若齢者の学習能力を向上させる方法
KR102655941B1 (ko) * 2018-08-13 2024-04-11 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 항산화 조성물
KR102655940B1 (ko) * 2018-08-13 2024-04-11 (주)아모레퍼시픽 신규 진세노사이드, 및 이를 포함하는 항염 조성물
KR102635196B1 (ko) * 2018-10-17 2024-02-13 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 미백 조성물
CN110990702B (zh) * 2019-12-04 2023-04-25 张家口智趣学科技有限公司 一种面向儿童自主阅读的推荐方法、客户端及服务器
KR102209028B1 (ko) * 2020-02-14 2021-01-28 주성수 증포 인삼열매 발효물을 유효성분으로 포함하는 퇴행성 뇌질환 예방 또는 치료용 약학적 조성물
CN115245177B (zh) * 2022-09-23 2023-01-17 云南省农业科学院园艺作物研究所 一种人参果采穗植株专用调节剂及其使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05960A (ja) * 1991-06-19 1993-01-08 Kanebo Ltd 慢性疲労症候群治療剤
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
KR20020035855A (ko) * 1999-08-30 2002-05-15 마쯔오 미쯔요시 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
CN100475225C (zh) * 2004-04-27 2009-04-08 吉林省宏久生物科技股份有限公司 人参果软胶囊及其制备方法
KR101043212B1 (ko) * 2004-11-03 2011-06-21 주식회사 한국인삼공사 뇌 기능 개선용 건강기능식품
US9314493B2 (en) 2007-05-28 2016-04-19 Amorepacific Corporation Method for treating vascular inflammation, improving skin beauty and improving male sexual function using ginseng berry
KR20080104600A (ko) 2007-05-28 2008-12-03 (주)아모레퍼시픽 인삼 열매 추출물을 함유하는 혈행촉진, 혈관신생촉진, 및허혈성 심질환 치료용 조성물
KR20080105470A (ko) * 2007-05-31 2008-12-04 (주)아모레퍼시픽 인삼 열매 추출물을 함유하는 비만 예방 및 개선용 식품조성물
KR100889950B1 (ko) * 2007-06-27 2009-03-20 박용진 신규한 홍삼의 제조방법 및 이를 함유하는 조성물
KR20110078524A (ko) * 2009-12-31 2011-07-07 (주)아모레퍼시픽 인삼 열매 추출물을 함유하는 퇴행성 신경장애 치료용 조성물
KR20110079564A (ko) * 2009-12-31 2011-07-07 (주)아모레퍼시픽 인삼 열매 추출물을 함유하는 미토콘드리아 활성화를 위한 조성물
CN101966292B (zh) 2010-10-07 2014-02-26 吉林省集安益盛药业股份有限公司 一种无糖型中药口服液及其制备方法
WO2013109051A1 (ko) * 2012-01-20 2013-07-25 씨제이제일제당(주) 인삼유래의 진세노사이드 rg3의 함량이 증강된 추출분획물을 유효성분으로 함유하는 기억력 또는 집중력 증진용 조성물

Also Published As

Publication number Publication date
EP2982376A1 (en) 2016-02-10
EP2982376A4 (en) 2017-01-04
WO2014163328A1 (ko) 2014-10-09
KR102200012B1 (ko) 2021-01-08
EP2982376B1 (en) 2019-08-14
CN104095894A (zh) 2014-10-15
KR20140120264A (ko) 2014-10-13
CN113244282A (zh) 2021-08-13
US10555983B2 (en) 2020-02-11
US20160051605A1 (en) 2016-02-25
JP2016515611A (ja) 2016-05-30

Similar Documents

Publication Publication Date Title
JP6648004B2 (ja) 朝鮮人参の実抽出物を含む脳活性化組成物
KR102262306B1 (ko) 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
KR102064651B1 (ko) 여주 추출물, 구절초 추출물 및 작약 추출물을 유효 성분으로 포함하는, 당뇨 예방 또는 개선용 조성물
US9814749B2 (en) Composition for preventing or treating dementia containing prunus mume extract
JP2013203683A (ja) Ｉｉｉ型コラーゲン産生促進剤
DE60133781T2 (de) Orale zubereitungen mit juckreizlindernder oder antipruritischer wirkung
KR101316095B1 (ko) 진세노사이드 Ｒｂ１ 및 Ｒｇ３，Ｃｏｍｐｏｕｎｄ Ｋ，또는 인삼유래 사포닌 추출물을 유효성분으로 함유하는 신경병증성 통증 예방 및 치료용 조성물
KR101536974B1 (ko) 여주, 산수유, 오미자 및 대추의 혼합 추출물을 함유하는 당뇨 예방 및 개선용 조성물.
KR101931226B1 (ko) 결명자 추출물을 유효성분으로 포함하는 다낭성 난소 증후군 관련 질환의 예방, 개선 또는 치료용 조성물
HK40047500A (en) Composition for brain activation comprising ginseng berry extract
KR102362480B1 (ko) 반지련 추출물을 유효성분으로 포함하는 남성갱년기 증후군의 예방, 개선 또는 치료용 조성물
KR20130024942A (ko) 진세노사이드 Ｒｂ１ 및 Ｒｇ３，Ｃｏｍｐｏｕｎｄ Ｋ，또는 인삼유래 사포닌 추출물을 유효성분으로 함유하는 신경병증성 통증 예방 및 치료용 조성물
KR101651924B1 (ko) 배암차즈기 잎 추출물 및 발효 삼채 뿌리의 추출물을 포함하는 천식 치료용조성물
KR101222779B1 (ko) 식용피 추출물을 유효성분으로 함유하는 당뇨병 예방 및 치료용 약학조성물
HK1197375A (en) Brain activating composition comprising ginseng fruit extract
EP3922252A1 (en) Composition for enhancing vascular endothelial function
KR20220082396A (ko) 계혈등 추출물을 유효성분으로 포함하는 알러지성 질환의 예방, 개선 또는 치료용 조성물
KR20220126092A (ko) 석창포 추출물을 유효성분으로 포함하는 남성갱년기 증후군의 예방, 개선 또는 치료용 조성물
US20150238539A1 (en) Composition for brain-neuron protection and brain-disease prevention, alleviation or treatment comprising muskrat musk
KR102939527B1 (ko) 토맨토신을 유효성분으로 함유하는 우울증 및 불안증의 예방, 개선 또는 치료용 조성물
KR20250162029A (ko) 산수유 추출물을 유효성분으로 포함하는 근이영양증의 개선 또는 치료용 조성물
KR20250162030A (ko) 복령 추출물을 유효성분으로 포함하는 근이영양증의 개선 또는 치료용 조성물
KR20250162692A (ko) 가미소요산을 유효성분으로 포함하는 근이영양증의 개선 또는 치료용 조성물
KR20150006158A (ko) 참나물 추출물을 유효성분으로 포함하는 비알콜성 지방간 질환의 예방 또는 치료용 조성물
JP2026008962A (ja) 二日酔い症状を軽減するための組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180313

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180814

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181207

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20181225

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190821

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20191003

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200115

R150 Certificate of patent or registration of utility model

Ref document number: 6648004

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250